Kazia Therapeutics Limited Skyrocketed

Fri 07 Aug 20 at 05:30 PM
Kazia Therapeutics Limited Skyrocketed

Kazia Therapeutics Limited (KZIA:NASDAQ) soared at $6.4, a gain of 50.6%. On Thu 06 Aug 20, KZIA:NASDAQ hit a New 2-Week Intraday High of $4.5. The stock appeared on our News Catalysts scanner on Fri 07 Aug 20 at 11:13 AM in the 'BIOTECH' category. From Thu 23 Jul 20, the stock recorded 40.00% Up Days and 54.55% Green Days

The share price of the company has been moving sideways in recent weeks.

About Kazia Therapeutics Limited (KZIA:NASDAQ)

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, engaged in developing anti-cancer drugs. It has two clinical staged drug development candidates and an early stage discovery program.